Ixekizumab 80mg/mL, 1mL Injection$359.00
1–9 boxes
$359.00 each
10–24 boxes
8% off
25+ boxes
10% off
Ixekizumab 80mg/mL, 1mL Injection
SKU GME1092Immunology Care
Product Introduction
Ixekizumab 80mg/mL is a biological treatment for plaque psoriasis and inflammatory joint or spinal conditions such as psoriatic arthritis and axial spondyloarthritis.
How to use
This single-dose autoinjector delivers 80mg under the skin. Rotate injection sites and avoid tender, bruised or psoriasis-affected skin. The initial dose and timing of later doses depend on the condition and age. Use the autoinjector after training.
How it works
Ixekizumab binds to interleukin-17A and prevents it from activating its receptor. This reduces an inflammatory pathway involved in excessive skin-cell growth and inflammation of joints and the spine.
Side effects
Injection-site redness or pain, upper respiratory infections, nausea and fungal infections can occur. Severe allergy, persistent fever or a spreading infection needs prompt treatment. New persistent diarrhoea or bloody stools can signal inflammatory bowel disease.
Important information
Tuberculosis screening and vaccination assessment are part of preparation for treatment. Live vaccines are avoided during therapy. Tell your doctor about recurring infections, Crohn's disease or ulcerative colitis, pregnancy or breastfeeding before starting injections.
Uses
- Moderate-to-severe plaque psoriasis
- active psoriatic arthritis
- eligible forms of axial spondyloarthritis, including ankylosing spondylitis.
Benefits
Treatment can improve plaque clearance, itching and the impact of psoriasis on daily life. In responsive joint or spinal disease, it can lessen inflammatory stiffness and improve physical function.
Is ixekizumab a steroid?
No. It is a monoclonal antibody directed against IL-17A. It has a different mechanism and treatment schedule from corticosteroid tablets or creams.
Will treating my skin also treat psoriatic joint symptoms?
Ixekizumab can help both skin and joint disease, but the degree and timing of improvement may differ. Joint swelling and morning stiffness should be assessed separately from skin clearance.
Can an injection be given into a psoriasis plaque?
No. Choose unaffected skin and rotate sites. Injecting into inflamed plaques or damaged skin can increase discomfort and local irritation.
Why is bowel disease relevant to this treatment?
IL-17 blockade can trigger or worsen inflammatory bowel disease in some people. Persistent abdominal pain, diarrhoea or blood in the stool needs assessment even when the skin is improving.
IL-17A: inflammatory signalling protein. Monoclonal antibody: laboratory-made protein targeting a specific molecule. Plaque psoriasis: inflammatory disease causing raised scaly skin patches. Psoriatic arthritis: joint inflammation associated with psoriasis. Subcutaneous: beneath the skin.; AR: Ixekizumab 80mg/mL حقن; FR: Ixekizumab 80mg/mL préparation injectable; PT: Ixekizumab 80mg/mL injetável; ES: Ixekizumab 80mg/mL inyectable; RU: Ixekizumab 80mg/mL инъекционная форма; ID: Ixekizumab 80mg/mL injeksi; VI: Ixekizumab 80mg/mL thuốc tiêm; MS: Ixekizumab 80mg/mL suntikan; TL: Ixekizumab 80mg/mL iniksyon; ZH-SG: Ixekizumab 80mg/mL 注射剂